Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN140,08140,18-2,96
Msft3,05
Nokia11,9111,935-5,25
IBM0,43
Mercedes-Benz Group AG50,350,35-1,31
PFE-1,63
16.05.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 15.05.2026
Curaleaf Hldg Rg (US Other OTC (Pink Sheets))
Závěr k 15.5.2026 Změna (%) Změna (USD) Objem obchodů (ks)
3,41 -13,35 -0,53 1 125 733
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 16.05.2026
Popis společnosti
Obecné informace
Název společnostiCuraleaf Holdings Inc
TickerCURA
Kmenové akcie:Ordinary Shares Subordinate Voting
Kmenové akcie:Ordinary Shares Multiple Voting
RICCURA.TO
ISIN-
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky31.03.2026
Počet zaměstnanců k 31.12.2025 5 554
Akcie v oběhu k 05.05.2026 792 166 597
MěnaUSD
Kontaktní informace
Ulice420 Lexington Avenue
MěstoNEW YORK
PSČ10170
ZeměUnited States
Kontatní osobaCamilo Lyon
Funkce kontaktní osobyChief Investment Officer
Telefon17 814 510 117

Business Summary: Curaleaf Holdings, Inc. is an international provider of consumer products in cannabis. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof, provide service, product selection and accessibility across the medical and adult use markets. It has operations in about 17 states and operates 151 dispensaries, 19 cultivation sites and 20 manufacturing facilities, through which it sells cannabis through wholesale channels. The Company places a premium on populated, limited license states, including Arizona, Connecticut, Florida, Illinois, Maryland, Massachusetts, Nevada, New York, New Jersey, North Dakota, Ohio and Pennsylvania. It cultivates, processes, markets and/or dispenses a wide range of permitted cannabis products across its operating markets, including flowers, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, mints and lozenges, topical balms and lotions, tinctures, and others.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Curaleaf Holdings Inc revenues increased 6% to $324.2M. Net income before extraordinary items totaled $70.1M vs. loss of $50.9M. Revenues reflect International operation segment increase of 35% to $47.2M, Domestic operations segment increase of 2% to $277M, International segment increase of 35% to $47.2M, Domestic segment increase of 2% to $277M.
Odvětvová klasifikace
TRBC2012Recreational Pharmaceuticals
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Medicinal & Botanical Mfg
NAICS1997Medicinal and Botanical Manufacturing
SICMedicinals And Botanicals
SICPharmaceutical Preparations



  • Poslední aktualizace: 16.05.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerBoris Jordan5816.08.2024
PresidentRahul Pinto-16.06.202516.06.2025
Executive Vice Chairman of the BoardJoseph Lusardi5001.01.2021
Chief Financial OfficerEdward Kremer5308.08.202208.08.2022
Chief Investment OfficerCamilo Lyon4908.08.2022
Vice President - People and CultureRob Francin-12.08.202412.08.2024
Chief Legal OfficerPeter Clateman56